Telix Historical Financial Ratios
| TLX Stock | 14.70 0.07 0.47% |
Telix Pharmaceuticals is promptly reporting on over 54 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Stock Based Compensation To Revenue of 0.0, Capex To Depreciation of 0.18, ROIC of 0.18 or Inventory Turnover of 9.24 will help investors to properly organize and evaluate Telix Pharmaceuticals financial condition quickly.
Telix |
About Telix Financial Ratios Analysis
Telix PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Telix Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Telix financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Telix Pharmaceuticals history.
Telix Pharmaceuticals Financial Ratios Chart
Add Fundamental
Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Net Debt To E B I T D A
A leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA).Most ratios from Telix Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Telix Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At this time, Telix Pharmaceuticals' Intangibles To Total Assets are fairly stable compared to the past year. Debt To Equity is likely to rise to 0.12 in 2024, whereas Price To Sales Ratio is likely to drop 0.41 in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 0.21 | 3.66 | 5.73 | 11.12 | Days Of Inventory On Hand | 494.78 | 50.26 | 33.58 | 67.13 |
Telix Pharmaceuticals fundamentals Correlations
Click cells to compare fundamentals
Telix Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Telix Pharmaceuticals fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Days Sales Outstanding | 51.02 | 967.02 | 1.4K | 92.09 | 47.61 | 45.23 | |
| Ev To Sales | 0.41 | (16.18) | (3.98) | (0.68) | (0.21) | (0.2) | |
| Roic | 1.56 | (0.54) | (16.03) | (1.08) | 0.17 | 0.18 | |
| Inventory Turnover | 5.98 | 3.2 | 0.74 | 7.26 | 10.87 | 9.24 | |
| Days Of Inventory On Hand | 61.04 | 114.15 | 494.78 | 50.26 | 33.58 | 67.13 | |
| Payables Turnover | 13.81 | 0.35 | 0.21 | 3.66 | 5.73 | 11.12 | |
| Sales General And Administrative To Revenue | 0.24 | 3.85 | 7.13 | 0.5 | 0.16 | 0.15 | |
| Capex To Revenue | 0.0221 | 0.0688 | 0.27 | 0.0889 | 0.0217 | 0.0378 | |
| Interest Coverage | (1.7) | (39.8) | (14.42) | (14.37) | 1.3 | 1.36 | |
| Days Payables Outstanding | 26.44 | 1.0K | 1.7K | 99.65 | 63.7 | 60.51 | |
| Roe | 0.8 | (0.57) | (37.31) | (1.3) | 0.035 | 0.0367 | |
| Return On Tangible Assets | (0.12) | (0.46) | (1.49) | (0.53) | 0.0181 | 0.019 | |
| Ev To Free Cash Flow | (1.49) | 235.21 | 14.56 | 7.64 | 9.8 | 10.29 | |
| Intangibles To Total Assets | 0.0607 | 0.38 | 0.51 | 0.23 | 0.28 | 0.29 | |
| Net Debt To E B I T D A | 2.29 | 1.81 | 0.28 | 1.22 | (4.61) | (4.38) | |
| Current Ratio | 0.66 | 4.69 | 1.25 | 2.02 | 1.43 | 0.9 | |
| Receivables Turnover | 7.15 | 0.38 | 0.25 | 3.96 | 7.67 | 7.06 | |
| Debt To Equity | (0.52) | (0.67) | 0.0279 | 1.18 | 0.13 | 0.12 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.